31results about How to "Appropriate medication" patented technology

The invention relates to a medicine for treating esophagus cancer and a preparation method thereof. The preparation method is characterized by comprising the following steps: classifying musk, borneol, scorpio, ebony, centipede and eupolyphage sinensis, grinding into fine powder, removing impurities, blending, stirring evenly, then blending with honey, producing finished pills and weighing each pill by 5g. When being taken, one pill is taken, put into the mouth and dissolved by holding in the mouth, the pills are taken for 2 times each day and are respectively taken for 1 time in the morning and in evening, three weeks form one treatment course, and the pills are stopped taking for 1 week after one treatment course, and then are continuously dissolved by holding in the mouth for treatment. The formula is formed by adding and reducing matched treatment on the basis of the traditional formula and has little matched traditional Chinese medicines and low side effect; especially, an oral holding tablet has a therapeutic action on the esophagus cancer of the early period and the middle period and has an obvious effect of prolonging the life for a late-period patient.

The invention discloses an ambroxol hydrochloride osmotic pump controlled-release tablet and belongs to the field of preparation of ambroxol hydrochloride osmotic pump controlled-release tablets. The ambroxol hydrochloride osmotic pump controlled-release tablet comprises a tablet core composed of a drug-loading layer and a boosting layer; the tablet core is covered with a semipermeable film coating; one or more drug release pores is / are formed in the surface of the semipermeable film coating, and the semipermeable film coating is covered with a moisture-proof coating; the drug-loading layer is prepared from ambroxol hydrochloride, a suspending aid, a penetration enhancer, an osmotic pressure active material, a binder, a colorant and a lubricant; the boosting layer is prepared from the penetration enhancer, a macromolecular swelling material, the osmotic pressure active material, the colorant, the binder and the lubricant; the semipermeable film coating is prepared from a film material, a plasticizer, a pore-foaming agent and a solvent. The ambroxol hydrochloride osmotic pump controlled-release tablet has the advantages of convenient administration, long acting, release at an approximately constant rate in 0-12 hours, maintaining of stable blood concentration and reduction of toxic and side effects, decrease of times of taking medicine, appropriate table weight, enhancement of patient elasticity, and the like.

The invention provides a broad spectrum external traditional Chinese medicine preparation for skins. The preparation comprises the following components in percentage by weight: 20-56% of a cinnamomum burmannii extract, 15-30% of an asarum insigne extract, 15-25% of an extract of red psychotria leaves, 3-5% of a dye yam extract, 4-8% of eugenol, 3-4% of wintergreen oil and 4-8% of a transdermal agent. The broad spectrum external traditional Chinese medicine preparation for skins has the major functions of stopping bleeding, relieving pain and diminishing swelling, diminishing inflammation and relieving itching, eliminating putridity and engendering flesh and promoting wound healing and is suitable for blood seepage of damage outside the skins and symptoms for relieving pain and diminishing swelling, and can be further used for treating mange, skin and external diseases, unknown pyogenic infections and skin itch harmful to the skins, killing sarcoptes mites and louses, preventing mosquito bite and protecting the skins. The broad spectrum external traditional Chinese medicine preparation for skins provided by the invention changes the delivery system through merger of groups of traditional Chinese medicines integrated with the transdermal agent, so that the functions of the traditional Chinese medicines can be adequately exerted, and the use range of the preparation is expanded. The preparation has the characteristics of less dosage, good curative effect, short course and multipurpose by broad spectrum.

The invention relates to a composition and method for preventing and removing pests, and particularly relates to a composition and method for preventing and removing pests, capable of preventing and controlling various underground pests and soil diseases effectively and simultaneously. The composition for preventing and controlling pests is characterized by containing active components and an adjuvant, wherein the active components are a pesticide chlorpyrifos and a bacteriacide captan and the weight ratio of chlorpyrifos to captan is (50:1)-(1:50), and the active components, namely chlorpyrifos and captan, account for 5-80wt% of the composition. In the method for preventing and removing pests, chlorpyrifos and captan act on pests at the same time, or any one of chlorpyrifos and captan isused to act on the pests at first and then the other one is used to act on the pests.

The invention provides a broad spectrum external traditional Chinese medicine preparation for skins. The preparation comprises the following components in percentage by weight: 20-56% of a cinnamomum burmannii extract, 15-30% of an asarum insigne extract, 15-25% of an extract of red psychotria leaves, 3-5% of a dye yam extract, 4-8% of eugenol, 3-4% of wintergreen oil and 4-8% of a transdermal agent. The broad spectrum external traditional Chinese medicine preparation for skins has the major functions of stopping bleeding, relieving pain and diminishing swelling, diminishing inflammation and relieving itching, eliminating putridity and engendering flesh and promoting wound healing and is suitable for blood seepage of damage outside the skins and symptoms for relieving pain and diminishing swelling, and can be further used for treating mange, skin and external diseases, unknown pyogenic infections and skin itch harmful to the skins, killing sarcoptes mites and louses, preventing mosquito bite and protecting the skins. The broad spectrum external traditional Chinese medicine preparation for skins provided by the invention changes the delivery system through merger of groups of traditional Chinese medicines integrated with the transdermal agent, so that the functions of the traditional Chinese medicines can be adequately exerted, and the use range of the preparation is expanded. The preparation has the characteristics of less dosage, good curative effect, short course and multipurpose by broad spectrum.

The invention belongs to the technical field of traditional Chinese medicines and relates to use of a traditional Chinese medicine preparation in preparation of a drug for treating weakness-of-spleen-and-stomach type chronic gastritis. The traditional Chinese medicine preparation is prepared from atractylodes macrocephala, poria cocos, gordon euryale seed, coix seed, magnolia bark, hierochloe odorata, non-glutinous rice, angelica sinensis, panax ginseng and glycyrrhiza uralensis. The traditional Chinese medicine preparation complies with the prescription rule of assistant and guide, is appropriate in medication, strict in compatibility and clear between primary medicines and secondary medicines, gains mutually and can be used for reinforcing the spleen and nourishing the stomach, harmonizing stomach Qi, removing dampness and promoting diuresis, tonifying middle-Jiao and Qi and strengthening the spleen and replenishing Qi. The traditional Chinese medicine preparation for treating the weakness-of-spleen-and-stomach type chronic gastritis, disclosed by the invention, is strong in pertinence, high in effect showing speed, short in treatment course and high in cure rate. Medicated materials are all listed in the Chinese Pharmacopoeia, are simplified and are low in dosage, wide in source and low in cost, and a preparation process is simple and easy, so that the traditional Chinese medicine is suitable for industrial production.

The invention belongs to the technical field of traditional Chinese medicines and relates to an artemisia leaf-containing pharmaceutical composition for treating community-acquired pneumonia. The pharmaceutical composition is prepared from the artemisia leaves, radix scutellariae, elaeagnus pungens leaves, Sichuan fritillary bulb, radish seeds, radix adenophorae, lancea tibetica, radix ophiopogonis, citrus medica, dendrobium nobile, concretio silicea and glycyrrhiza uralensis. The pharmaceutical composition complies with the prescription rule of monarch, minister, adjuvant and conductant, is appropriate in medication, strict in compatibility and clear between primary and secondary, gains mutually and can be used for relieving asthma and cough, clearing heat and moistening lung and invigorating Qi and strengthening body resistance. During the treatment of the community-acquired pneumonia, the pharmaceutical composition is high in pertinence, obvious in treatment effect and high in cure rate.

The invention discloses an ambroxol hydrochloride osmotic pump controlled-release tablet, which belongs to the field of preparation of ambroxol hydrochloride osmotic pump controlled-release tablets. The ambroxol hydrochloride osmotic pump controlled-release tablet of the present invention comprises a tablet core composed of a drug-containing layer and a booster layer, the tablet core is covered with a semipermeable film coat, and one or more small drug release holes are arranged on the surface of the semipermeable film coat , pack moisture-proof clothing; Described drug-containing layer is made up of ambroxol hydrochloride, suspending agent, penetrating agent, osmotic pressure active substance, binding agent, colorant and lubricant; Described booster layer is made up of penetrating agent, It is composed of polymer swelling material, osmotic pressure active substance, coloring agent, adhesive and lubricant; the semipermeable film coating is composed of film material, plasticizer, porogen and solvent. The ambroxol hydrochloride osmotic pump controlled-release tablet of the present invention has the advantages of convenient administration, long-lasting effect, release at an approximately constant rate for 0-12 hours, maintains stable blood drug concentration, reduces toxic and side effects, reduces the number of times of taking medicine and has a suitable tablet Weight, enhance patient compliance and other advantages.

The invention provides a germ-free powder injection for treating cow mammitis and its preparing process, wherein the injection comprises lactic acid streptostacin to replace antibiotics in cow mammitis treatment, as a result, no unwanted residual to human body is formed in milk. The injection also has the advantages of controllable quality, better stability and convenience in transportation.

The invention belongs to the field of pharmaceutical chemical engineering, and discloses a L-ornithine lipoic acid compound salt, and a preparation method and application thereof. A structural formula of the L-ornithine lipoic acid compound salt is as shown in the formula I. The L-ornithine lipoic acid compound salt has functions of preventing and treating hepatic coma caused by acute and chronic hepatic diseases such as liver cirrhosis, fatty liver, hepatitis and the like and can be used for preparing a medicament for treating hepatic coma. The preparation method for the L-ornithine lipoic acid compound salt is simple and easy to operate and is low in cost; the product is high in purity.

The invention relates to a freeze-dried powder, in particular to a water-soluble polypeptide drug slow-release long-acting injection technical field, goserelin slow-release microsphere freeze-dried powder and a preparation method thereof. Each microsphere in the freeze-dried powder includes an outer shell, the outer shell wraps the inner core, and the inner core is a temperature-sensitive gel. The temperature-sensitive gel has good fluidity when it is lower than the body temperature, and the fluidity decreases and then gels when the temperature rises to body temperature. , forming a gel core and a shell of biodegradable material. The advantages and effects of the present invention: the encapsulation rate of the present invention reaches over 90%, and the drug release is controlled by the internal temperature-sensitive gel core and the external biodegradable slow-release framework material, which is a double-layer drug release system.